Silver Book Fact

The number of cases of visual impairment and blindness from age-related macular degeneration (AMD0 is projected to increase from 620,000 in 2010 to 1.6 million in 2050–assuming no treatments.

Rein D, Wittenborn J, Zhang X, Honeycutt A, et al. Forecasting Age-Related Macular Degeneration Through the Year 2050. JAMA Ophthalmol. 2009; 127(4): 533-40. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/422785

Reference

Title
Forecasting Age-Related Macular Degeneration Through the Year 2050
Publication
JAMA Ophthalmol
Publication Date
2009
Authors
Rein D, Wittenborn J, Zhang X, Honeycutt A, et al
Volume & Issue
Volume 127, Issue 4
Pages
533-40
URL
Read Full Resource

Categories

  • Cost of Disease
  • Future Human Burden

Related Facts

  • The total annual loss for the 3.7 million people in the U.S. who are visually impaired or blind is estimated at more than 209,000 quality-adjusted life-years.  
  • In 2001, an estimated 1.4 million age-related macular degeneration (AMD) patients visited physicians or hospitals for treatment of their disease.  
  • More than 1 in 10 Americans over the age of 80 has advanced age-related macular degeneration (AMD)– 1.08 million Americans 80 and older.  
  • An estimated 2.3 million Americans 40 and older currently have glaucoma. That number is expected to grow by 50% to 3.36 million by 2020.  
  • The average direct cost of glaucoma treatment ranges from $623 per year for patients with early-stage glaucoma, to $2,511 per year for end-stage patients. Medication costs make up the largest…